✦ LIBER ✦

Long-term outcome of a phase II study of weekly docetaxel with a short course of estramustine and enoxaparine in hormone-resistant prostate cancer patients

✍ Scribed by A. González-Martín; E. Fernández; M. A. Vaz; J. Burgos; M. López García; R. Rodríguez Patrón; C. Guillén; T. Mayayo; A. Allona; F. Arias; A. Moyano

Book ID: 107596220
Publisher: Springer Milan
Year: 2007
Tongue: Spanish
Weight: 92 KB
Volume: 9
Category: Article
ISSN: 1699-048X
DOI: 10.1007/s12094-007-0060-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II trial of docetaxel and vinore

A phase II trial of docetaxel and vinorelbine in patients with hormone-refractory prostate cancer

✍ Susan Goodin; Kamakshi V. Rao; Michael Kane; Nisha Dave; Terry Capanna; Susan Do 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 200 KB

A phase I/II dose-escalation study of ex

A phase I/II dose-escalation study of exisulind and docetaxel in patients with hormone-refractory prostate cancer

✍ Christopher W. Ryan; Walter M. Stadler; Nicholas J. Vogelzang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

A Phase I/II study of weekly paclitaxel

A Phase I/II study of weekly paclitaxel and 3 days of high dose oral estramustine in patients with hormone-refractory prostate carcinoma

✍ Anna C. Ferrari; Abraham Chachoua; Harvinder Singh; Mark Rosenthal; Samir Taneja 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB 👁 2 views

Results from a pilot Phase I trial of ge

Results from a pilot Phase I trial of gefitinib combined with docetaxel and estramustine in patients with hormone-refractory prostate cancer

✍ George Wilding; Patrick Soulie; Donald Trump; Ashis Das-Gupta; Eric Small 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

A Phase II study of estramustine, doceta

A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony-stimulating factor support in patients with hormone-refractory prostate carcinoma : Cancer and Leukemia Group B 99813

✍ William K. Oh; Susan Halabi; W. Kevin Kelly; Cary Werner; Paul A. Godley; Nichol 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 98 KB 👁 2 views

## Abstract ## BACKGROUND The authors determined the safety and efficacy of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor (G‐CSF) support in patients with hormone‐refractory prostate carcinoma. ## METHODS In the current multicenter, cooperative group study,

A phase 2 study of estramustine, docetax

A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate-resistant prostate cancer : Results from Cancer and Leukemia Group B Study 90006

✍ Joel Picus; Susan Halabi; W. Kevin Kelly; Nicholas J. Vogelzang; Young E. Whang; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 184 KB 👁 2 views